Clinical Update: A Nonhealing Fractured Mandible
Authors:
- Catherine BurkeCBCatherine Burke
- Diane CopeDCDiane Cope
- 1 December 2005
- journal article
- case report
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 9 (6) , 685-7
Abstract
Bisphosphonates have shown significant clinical benefit in reducing skeletal fractures in patients with multiple myeloma or bone: penicillin VK 500 mg or amoxicillin 500 mg; both 4 times daily (QID) initially and twice daily (BID) for maintenance, If penicillin allergic: 1. Clindamycin 150 to 300 mg QID. 2. Vibramycin 100 mg once daily (QD). 3. Erythromycin ethylsuccinate 400 mg 3 times daily (TID). 4. Antifungals when required: 5. Nystatin oral suspension 5 to 15 mL QID or 100,000 IU/mL. 6. Mycelex troches (clotrimazole 10 mg) x 5/day. 7. Fluconazole 200 mg initially, then 100 mg QD. 8. Other potential systemic antifungals include itraconazole or ketoconazole. 9. Antivirals, if required: 10. Acyclovir 400 mg BID. 11. Valacyclovir hydrochloride 500 mg to 2g BID.Keywords
This publication has 5 references indexed in Scilit:
- Exposed Bone in Oral CavitiesClinical Journal of Oncology Nursing, 2005
- Bisphosphonates and avascular necrosis of the jaw: a possible associationMedical Journal of Australia, 2005
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Bisphosphonates: Expanded Roles in the Treatment of Patients With CancerClinical Journal of Oncology Nursing, 2003